INTRODUCTION
============

Neurologic symptomatology that develops unconsciously and is not related to known pathophysiologic mechanisms or anatomic pathways is called Conversion Disorder (CD), which is actually classified under the "Functional Neurological Symptom Disorder" (FNS) in the DSM-5 \[[@b1-pi-2017-10-16-2]\]. CD diagnosis is mainly based on the exclusion of physical disorders causing significant distress or social and occupational impairment. CD incidence is between 4 and 12 cases per 100,000 habitants/year, although its exact prevalence is unknown \[[@b1-pi-2017-10-16-2]\]. In a subgroup of CD, called functional weakness or paralysis (FW) (DSM-5 300.11/ICD-10 F44.4), symptoms affecting limbs may be persistent, thus causing a permanent or transient loss of limb function \[[@b1-pi-2017-10-16-2]\].

Physiotherapy, pharmacotherapy, and hypnotherapy have been proposed as treatment strategies for FW-CD in the past years \[[@b2-pi-2017-10-16-2]-[@b4-pi-2017-10-16-2]\], showing a variable and heterogeneous symptoms recovery. Recently, it has been suggested that multidisciplinary approach including behavioral and motor learning programs could represent the most effective FW therapy \[[@b2-pi-2017-10-16-2]\]. Besides, repetitive transcranial magnetic stimulation (rTMS) is currently used as an adjunctive treatment option in different neuropsychiatric conditions, including CD \[[@b5-pi-2017-10-16-2]\]. Herein, we report the case of a 30 year-old male, who developed functional paraparesis due to psychological factors, rapidly and stably recovered by a multidisciplinary approach including rTMS.

Case
====

The patient is a 30 year-old man, second child from nonconsanguineous parents, born preterm (at 32 weeks) by Caesarean section. He was in incubator for two weeks. Family history was unremarkable. He presented normal psychomotor milestones. From 10 to 18 years-old, he presented with a growth hormone deficit, treated with a replacement therapy. At our observation (October 2016), he complained of low back pain and gait difficulties, worsened by physical exercise, for about 10 years. At neurological examination, the patient presented with paraparesis so that gait was possible only with two canes; muscle strength assessment was difficult to evaluate since he complained of intense low back pain. Nonetheless, no objective signs of the central and peripheral nervous system impairment were detected. Psychological evaluation showed depressed mood, marked anxiety, severe phobic cues with hypocondria, and poor emotional control, according to the Minnesota Multiphasic Personality Inventory-2 score (MMPI-2) \[[@b6-pi-2017-10-16-2]\] and Hamilton Rating Scale for Depression (HRS-D) (score: 18) \[[@b7-pi-2017-10-16-2]\].

The sexual counselling did not point out any sexual dysfunction. The patient was in a stable homosexual relationship, but his sexual orientation disappointed his relatives. Indeed, the first ever time he presented the ambulation deficit was somehow related to his coming-out, and he had the main symptom exacerbation following family's quarrels over his sexuality. Because of these symptoms, he underwent several investigations, including brain and spinal cord MRI with contrast medium, hips and pelvis X-ray, a complete neurophysiological evaluation (multi-modal evoked potentials, electromyography), blood tests (including inflammatory and autoimmune markers and muscle enzymes dosages), all within the normal range.

Therefore, the patient was diagnosed with FW-CD and thus recruited for an rTMS treatment, which consisted of 100 stimuli at 100% maximum stimulator output, randomly delivered to the right and left primary motor cortex of the armhand and leg motor areas, at 1 Hz, three times a week for three months. This protocol was adapted to the patient, employing the stimulation paradigms of previous studies ([Table 1](#t1-pi-2017-10-16-2){ref-type="table"}). The patient gave his written informed consent.

Psychological evaluation and gait-analysis were performed before (T0) and after the end (T1) of the rTMS protocol to evaluate rTMS after-effects. The gait analysis was performed by using the OptoGait system (Version 1.6.4.0, Microgate, Bolzano, Italy) \[[@b8-pi-2017-10-16-2]\].

T0, we found abnormal values of each phase of gait and the temporal parameters of the gait, i.e., gait cycle (5,646±2.553 sec), cadence (19±13.8 step/min), and step time with a preservation of the step and stride length. The visual analogue scale (VAS) for low back pain yielded a score 7/10.

At T1, the subject reported an improvement in mood and anxiety (HRS-D: 7), hysteria and hypochondria items of the MMPI-2, and lower limb "weakness" with pain relief (VAS 3/10), being thus able to walk independently. We also found a significant improvement in the spatial, and temporal gait parameters (gait cycle: 1,707±1.2 sec; cadence 68.4±18.4 step/min).

DISCUSSION
==========

FW-CD has a still not known underlying etiological mechanism. Although the former criterion contained in DSM-IV considered psychological factors as essential to perform FWCD diagnosis \[[@b9-pi-2017-10-16-2]\], actually the DSM-V removed this aspect, considering that FW-CD are caused by a neurobiological component, even though stressful events may be possible causal concomitant factors influencing patients' vulnerability \[[@b10-pi-2017-10-16-2]\].

Treating FW-CD disorders using TMS was firstly postulated by Jellinek et al. in the nineties \[[@b11-pi-2017-10-16-2]\]. Few years later, other authors showed that rTMS induces long-lasting clinical improvement by stimulating cortical areas and inducing changes in cortical excitability and the interconnected brain areas, even in FWCD patients \[[@b12-pi-2017-10-16-2]\]. The supporting available literature on the use of rTMS in FW-CD is very sparse, so any assumption of a beneficial effect needs to be seen with caution. Recently, a systematic review reported only 5 articles describing FW-CD treated by rTMS ([Table 1](#t1-pi-2017-10-16-2){ref-type="table"}) \[[@b13-pi-2017-10-16-2]\], using different approaches and protocols \[[@b14-pi-2017-10-16-2]-[@b18-pi-2017-10-16-2]\]. All of these FW-CD cases gained a short-term symptom improvement. Trying to understand the rTMS efficacy in FW-CD has been the objective of an increasing body of literature data, suggesting that focal functional abnormalities in central networks controlling motor cortex activity may play a role in the etiology of FW-CD \[[@b10-pi-2017-10-16-2]\], thus gaining positive effect by rTMS. The mechanisms of action by which rTMS seems to be really effective in these patients have been explained by the combined physiological, neurophysiological and neuromodulatory induced effects \[[@b13-pi-2017-10-16-2]\]. Considering the physiological aspects of the rTMS, the crucial effect of supra-threshold rTMS is related to the individual's perception of the movements of their paralyzed limb induced by an external trigger, making them aware of the possibility of regaining the function. Furthermore, TMS exerts an additional placebo effect, especially if the information and the style used to inform the patients about the beneficial effects of this treatment strategy and purpose have been properly described \[[@b13-pi-2017-10-16-2]\].

The neurophysiological mechanism of action of the rTMS has been supported by an increasing body of literature data, suggesting that focal functional abnormalities in central networks may be related to an unbalance between motor intention and motor execution or an overactive self-monitoring with enhanced limbic neural activity, which interferes with movement planning, beginning within the frontal regions and thereby disrupting motor execution \[[@b19-pi-2017-10-16-2]\]. Moreover, functional-imaging methods demonstrated enhanced neural activity within the anterior cingulate area or orbito-frontal cortex and reduced neural activity within prefrontal motor areas during movement execution of the paralyzed limb in FWCD patients \[[@b20-pi-2017-10-16-2]\]. These abnormal activation patterns can be the cause of the unconscious inhibition of movement planning and execution.

Finally, it has also been reported that, considering the neuromodulatory induced rTMS effects, a short-lasting rTMS protocols might not cause a durable change in cortical activity, whereas long-lasting changes in cortical neuro-plasticity might only be induced performing longer protocols (e.g., for one or more weeks) , thus leading to long-term potentiationusing high-frequency (\>1 Hz) or long-term depression-like changes using low-frequency (≤1 Hz) \[[@b14-pi-2017-10-16-2]\].

Notably, in this case, we objectively documented the improvement using objective outcome measures (i.e. gait analysis) that lacks in the previous reported studies.

In our case, having obtained positive, objectively, and stable effects from r-TMS, we can postulate that our rTMS protocol, combined with a multidisciplinary approach (including a psychological and sexuological support) may be beneficial for symptoms improvement.

###### 

Comparison of the rTMS studies on FW-CD

  Study                                                              FW patients                        Clinical presentation                              rTMS protocol                       Outcome
  ------------------------------------------------------------------ ---------------------------------- -------------------------------------------------- ----------------------------------- ------------------------------------------------------------------------------------------------------
  14                                                                 3 (1 male) about 38 years of age   Not detailed, since 5 weeks to 5 years             M1                                  Marked improvement
  15 Hz                                                                                                                                                                                        
  5 times/week for 2 weeks                                                                                                                                                                     
  110% RMT then 90% RMT up to 12 weeks                                                                                                                                                         
  15                                                                 70 (8-79 years) of age             55 Acute (since 4 days)                            M1                                  Immediately or within hours in 89%
  iTBS                                                                                                                                                                                         
  15 chronic (since 240 days)                                        1-2 session in one day                                                                                                    
  100% MSO                                                                                                                                                                                     
  16                                                                 1 male, 24 years of age            Hemiparesis that compromised walking               Vertex stimulation                  patient able to walk again independently, immediately after
  Patterned rTMS^[\*](#tfn1-pi-2017-10-16-2){ref-type="table-fn"}^                                                                                                                             
  17                                                                 1 male, 33 years of age            Quadriplegia since 6 months                        Right and left M1-HAND and M1-LEG   Initially progressive amelioration; then, further deterioration leading a new rTMS with amelioration
  1 Hz                                                                                                                                                                                         
  5 times/week for 8 weeks and, after, twice a week                                                                                                                                            
  18                                                                 11 (4 males), 34-64 years of age   Flaccid hand paralysis since 4 weeks to 25 years   Contralateral M1 stimulation        Improve in muscle strength
  15 Hz                                                                                                                                                                                        
  5 times/week for 2 weeks                                                                                                                                                                     
  Our case                                                           1 male, 30 years of age            Flaccid paraparesis                                Right and left M1-HAND and M1-LEG   Marked improvement up to resolution
  1 Hz                                                                                                                                                                                         
  3 times/week for 3 months                                                                                                                                                                    
  100% MSO                                                                                                                                                                                     

single rTMS session with 12 single pulses at initially 30% maximal stimulator output intensity and increasing I in 10% steps up to 80% of maximal stimulator output.

MSO: maximal stimulator output, TBS: theta-burst stimulation, RMT: resting motor threshold
